Abstract
Summary
Guanethidine elicits a period of augmented myocardial contractility. Significant decrements in ventricle and aorta norepinephrine content are caused by the drug. With isolated hearts, the agent releases norepinephrine.
Get full access to this article
View all access options for this article.
